Migraine study attributes more than half a drug’s benefit to placebo effect
The information that clinicians provide to patients about a medication prescribed for their migraines can influence the magnitude of pain relief induced by the treatment, reports a study published online today in Science Translational Medicine. The findings suggest that patients who receive positive messages about the potential efficacy of their treatment may have better treatment outcomes than patients who receive negative messages. Read more